ICB PHARMA TOMASZ ŚWIĘTOSŁAWSKI,PAWEŁ ŚWIĘTOSŁAWSKI SPÓŁKA JAWNA
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
ICB PHARMA TOMASZ ŚWIĘTOSŁAWSKI,PAWEŁ ŚWIĘTOSŁAWSKI SPÓŁKA JAWNA
Contacts
Registered address
Copy
Website
WWW.ICBPHARMA.PL
Not calculatedReliability
Prescore cannot be calculated – company is not active.
Incorporation date
10/02/2003Share capital
No dataPrimary activity
-Representatives
0Representatives rights
WYMAGANE WSPÓŁDZIAŁANIE DWÓCH WSPÓLNIKÓW ŁĄCZNIERepresentatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
18,495,000Net Profit (zł)
18,495,000Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 88,096,000 |
| 21,763,000 |
| 21,763,000 |
| 0.33 |
| 3.22 |
| 24.70 |
| 50,272,000 |
| 13,162,000 |
| 2,509,000 |
| 24,929,000 |
| 2023 |
|---|
| 86,779,000 |
| 18,035,000 |
| 18,035,000 |
| 0.43 |
| 4.74 |
| 20.78 |
| 59,374,000 |
| 9,929,000 |
| 3,789,000 |
| - |
| 2024 |
|---|
| 92,540,000 |
| 18,495,000 |
| 18,495,000 |
| 0.50 |
| 4.55 |
| 19.99 |
| 68,835,000 |
| 13,015,000 |
| 3,636,000 |
| - |
| 2024 |
|---|
| 92,540,000 |
| 18,495,000 |
| 18,495,000 |
| 0.50 |
| 4.55 |
| 19.99 |
| 68,835,000 |
| 13,015,000 |
| 3,636,000 |
| - |
Turnover (zł)
2024
Turnover (zł)
92,540,000 zł
7 % *
Profit before tax (zł)
18,495,000 zł3 % *
Net Profit (zł)
18,495,000 zł3 % *
Working capital requirement (%)
0.50 
16.28 % *
Liquidity ratio
4.55 
-4.01 % *
Net profitability (%)
19.99 %-3.80 % *
Equity (zł)
68,835,000 zł16 % *
Current liabilities (zł)
13,015,000 zł31 % *
Non current liabilities (zł)
3,636,000 zł-4 % *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
ICB PHARMA TOMASZ ŚWIĘTOSŁAWSKI,PAWEŁ ŚWIĘTOSŁAWSKI SPÓŁKA JAWNA Documents
Date | Description |
|---|---|
26/03/2025 | OD 01.01.2024 DO 31.12.2024 |
25/03/2024 | OD 01.01.2023 DO 31.12.2023 |
31/03/2023 | OD 01.01.2022 DO 31.12.2022 |
22/03/2022 | OD 01.01.2021 DO 31.12.2021 |
19/03/2021 | OD 01.01.2020 DO 31.12.2020 |